Roni Mamluk

Director/Board Member at REDHILL BIOPHARMA LTD.

Net worth: 3 M $ as of 30/05/2026

59 year

66 connections

Health Technology

Consumer Services

Finance

Profile

Roni Mamluk currently works at RedHill Biopharma Ltd., as Independent Director from 2024 and Israel Biotech Fund, as Venture Advisor.
Dr. Mamluk also formerly worked at Old Ayala, Inc., as President, Chief Executive Officer & Director, Chiasma, Inc., as Independent Director from 2017 to 2021, Chiasma (Israel) Ltd., as Director from 2017 to 2021, Amryt Pharma Holdings Ltd., as Non-Executive Director, Amryt Pharma Ltd., as Non-Executive Director from 2021 to 2023, and Adnexus, as Head-Non Clinical Research & Development.
Dr. Mamluk received her undergraduate degree and doctorate degree from The Hebrew University of Jerusalem and graduate degree in 2004 from Harvard Medical School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
REDHILL BIOPHARMA LTD. 0.05%	26/04/2026	28,120,000 ( 0.05% )	3 M $	30/05/2026

Roni Mamluk active positions

Companies	Position	Start
REDHILL BIOPHARMA LTD.	Director/Board Member	31/08/2024
Israel Biotech Fund Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements.	Consultant / Advisor	-

All active positions of Roni Mamluk

Former positions of Roni Mamluk

Companies	Position	End
ADVAXIS, INC.	Chief Executive Officer	18/01/2023
AMRYT PHARMA PLC	Director/Board Member	31/12/2022
Chiasma (Israel) Ltd.	Director/Board Member	31/07/2021
CHIASMA, INC.	Chief Executive Officer	16/06/2015
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases	Director/Board Member	-

See the detail of Roni Mamluk's experience

Training of Roni Mamluk

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Roni Mamluk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Chiasma, Inc. Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease	Health Technology
Adnexus Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists	Health Technology
The Hebrew University of Jerusalem The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Chiasma (Israel) Ltd.
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RedHill Biopharma Ltd. RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services	Health Technology
Israel Biotech Fund Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements.	Finance
Amryt Pharma Holdings Ltd. Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases	Health Technology
Old Ayala, Inc. Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies	Health Technology
Amryt Pharma Plc Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases	Health Technology